Deadline: September 18, 2026$8.5M

DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Offered by Defense Health Agency Contracting Activity - DHACA; awards $8.5M; applications due September 18, 2026.

Key Facts

Funder
Defense Health Agency Contracting Activity - DHACA
Award amount
$8.5M
Deadline
September 18, 2026
Geography
United States
Categories
Research
Status
Open

About This Grant

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged. Distinctive Features: The FY26 CTRA...

Full requirements and application instructions: official listing.

Similar Open Grants

Deadlines Move. Your Search Shouldn't Start Over.

Get matched to open grants by eligibility and track every deadline in one workspace.